ANG1005 in Leptomeningeal Disease From Breast Cancer

Clinical trial NCT03613181 · UNKNOWN

Trial details

NCT number: NCT03613181
Sponsor: Angiochem Inc
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Leptomeningeal Carcinomatosis Leptomeningeal Metastases Brain Metastases HER2-negative Breast Cancer

Start date: 2023-12-01
Primary completion: 2024-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.